155 related articles for article (PubMed ID: 2499104)
1. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J; Schwenk J
Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
[No Abstract] [Full Text] [Related]
4. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].
Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R
Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124
[TBL] [Abstract][Full Text] [Related]
5. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein.
Ichihara T; Sakamoto J; Nakao A; Furukawa K; Watanabe T; Suzuki N; Horisawa M; Nagura H; Lloyd KO; Takagi H
Cancer; 1993 Jan; 71(1):71-81. PubMed ID: 8416729
[TBL] [Abstract][Full Text] [Related]
6. Lex and Ley antigen expression in human pancreatic cancer.
Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of carbohydrate antigens (CA 19-9, CA-50) in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Acta Histochem Suppl; 1990; 38():183-7. PubMed ID: 2080240
[No Abstract] [Full Text] [Related]
8. Stage-specific expression of cancer-associated type 1 and type 2 chain polylactosamine antigens in the developing pancreas of human embryos.
Tuo XH; Itai S; Nishikata J; Mori T; Tanaka O; Kannagi R
Cancer Res; 1992 Oct; 52(20):5744-51. PubMed ID: 1394198
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
11. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.
Pour PM; Tempero MM; Takasaki H; Uchida E; Takiyama Y; Burnett DA; Steplewski Z
Cancer Res; 1988 Oct; 48(19):5422-6. PubMed ID: 3166398
[TBL] [Abstract][Full Text] [Related]
12. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer.
Schuessler MH; Pintado S; Welt S; Real FX; Xu M; Melamed MR; Lloyd KO; Oettgen HF
Int J Cancer; 1991 Jan; 47(2):180-7. PubMed ID: 1988363
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings.
Safi F; Roscher R; Bittner R; Schenkluhn B; Dopfer HP; Beger HG
Pancreas; 1987; 2(4):398-403. PubMed ID: 3306667
[TBL] [Abstract][Full Text] [Related]
14. Expression of carbohydrate antigens in human pulmonary adenocarcinoma.
Kawai T; Suzuki M; Kase K; Ozeki Y
Cancer; 1993 Sep; 72(5):1581-7. PubMed ID: 8394200
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of CA 19-9 and CA 50 in relation to Lewis blood cell status in patients with malignant and benign pancreatic disease.
von Rosen A; Linder S; Harmenberg U; Pegert S
Pancreas; 1993 Mar; 8(2):160-5. PubMed ID: 8460090
[TBL] [Abstract][Full Text] [Related]
16. Expression of C-242 antigen in pancreatic ductal adenocarcinoma.
Mäkinen K; Eskelinen M; Lipponen P; Alhava E
Anticancer Res; 1995; 15(4):1605-8. PubMed ID: 7654056
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on the expression of gastrointestinal-cancer-associated antigen, PA8-15, CA19-9 and the blood-group antigens in non-malignant and malignant human pancreatic tissues.
Egami H; Sakamoto K; Yoshimura R; Arai M; Takiyama Y; Pour PM
J Cancer Res Clin Oncol; 1990; 116(4):365-71. PubMed ID: 2391357
[TBL] [Abstract][Full Text] [Related]
18. Blood-group antigen expression during pancreatic cancer induction in hamsters.
Pour PM; Uchida E; Burnett DA; Steplewski Z
Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427
[TBL] [Abstract][Full Text] [Related]
19. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
20. Blood group antigen expression in developing pancreas and in induced pancreatic cancer cells in Syrian hamsters.
Takiyama Y; Egami H; Pour PM
Carcinogenesis; 1990 Apr; 11(4):577-82. PubMed ID: 1969774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
